Ayala Pharmaceuticals Inc (ADXS)

[mypekeispooped]

Supposedly, Q1 for ADXS-PSA, ADXS-NEO and start of the IST in H&N. HOT data by end of Q2. I still like the look of the PSA trial so far (slide 15) on the CP. Part A: N=12, Events=9, Median=7.79. Combo Part B (both PSA drop of <50%/>50%): N=36, Events=7, Median=NR. Broken down, the >50% is better.